Back to 
Carlyle Group Inc.
Carlyle Group Inc.SPSPRB
4 quarters
Position history for Carlyle Group Inc.'s holdings in Spruce Biosciences, Inc.
Yes. Carlyle Group holds 38,620 shares of SPRB (Spruce Biosciences), worth $2.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Carlyle Group has held SPRB since Q3 2025, across 4 quarterly 13F filings.
Current Value
$2.1M
Current Shares
38,620
Total Value Change
-$22.7M
Total Shares Change
-2.9M
Quarter-by-Quarter History